Biosurgery Market Size to Reach USD 17.60 Billion in 2028, Says Reports and Data

- Surging incidence of chronic disorders and increasing number of sports-related injuries & road accidents are key factors driving market revenue growth

NEW YORK, Oct. 20, 2021 /PRNewswire/ -- The global biosurgery market size is expected to reach USD 17.60 billion in 2028 and register a revenue CAGR of 5.4% over the forecast period, according to the latest report by Reports and Data. Steady market revenue growth of biosurgery can be attributed to increasing geriatric population and obesity globally. These factors are contributing to rising prevalence of neurological disorders and arthritis.

Increasing number of reconstructive and orthopedic surgical procedures is also driving demand for biosurgery products. Biosurgery products are utilized during different surgical procedures to help minimize blood loss. These products include chemical and biological products that are used to stop bleeding among others during surgeries.

Furthermore, rising number of individuals suffering from chronic disorders is driving demand for surgeries. Biosurgery can be used for the treatment, prevention, and management of infected wounds. It is beneficial for neurological, reconstructive, gynecological, and other types of surgeries. Increasing incidence of sports-injuries and ongoing development of advanced products are also expected to boost market revenue growth.

However, limitation in the number of clinical trials, lack of awareness about biosurgery in developing countries, high cost of these procedures, and poor reimbursement policies may hamper market revenue growth in the coming years.

Download Report Sample PDF - https://www.reportsanddata.com/sample-enquiry-form/4612

Some Key Highlights From the Report:

• By application, the reconstructive surgery segment revenue is expected increase at a significantly rapid rate over the forecast period. Biosurgery products provide structural support during the healing process after reconstructive surgeries. Adoption of biosurgery has had a positive success rate and these can minimize risks associated with treatment, which, in, turn, would increase demand in the market.
• By end-use, ambulatory surgical centers segment revenue is expected expand at a significantly rate over the forecast period. Surgical centers provide same-day surgical care. Besides, higher incidence of sports injuries and road accidents would propel growth of this segment in the coming years.
• Biosurgery market in Asia Pacific is expected to witness fastest revenue CAGR over the forecast period. Ongoing developments in healthcare infrastructure, increasing number of patients with knee injuries, increasing gynecological disorders, and rising awareness among patients and physicians about benefits of biosurgery are expected to drive Asia Pacific market revenue growth.
• RND offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough, request for custom research report
• In February 2020, Baxter International Inc. announced 510 (k) clearance from US FDA for its new generation Peri-Strips Dry with Veritas Collagen Matrix (PSDV) product. It has Secure Grip feature, and is equipped with 'peel and secure' technology and is a staple-line reinforcement material. It can be used for mitigating bleeding during bariatric surgeries and other surgical procedures.
• In October 2020, Orthofix Medical Inc. introduced O-GENESIS Graft Delivery System virtually amid the North American Spine Society (NASS) 2020. The company also launched AlloQuent Structural Allograft Q-Pack, which is a ready-to-use, hydrated form of lumber and cervical spacers for allograft procedures. O-GENESIS, on the other hand, would provide allograft, autograft, or synthetic bone graft to orthopedic surgical sites.
• Major players in the market report include Baxter International Inc., B. Braun Melsungen AG Becton, Dickson and Company, CSL Limited, Cryolife Inc., Hemostasis LLC, Integra Lifesciences Holding Corporation, Johnson & Johnson, Kuros Biosciences AG, Medtronic PLC, Smith & Nephew Plc., and Zimmer Biomet.

To Identify The Key Trends In The Industry, Research Study At https://www.reportsanddata.com/report-detail/biosurgery-market

For the purpose of this report, Reports and Data has segmented biosurgery market based on product type, end-use, application, and region:

Product Type Outlook (Revenue, USD Billion; 2018-2028)

• Bone-graft Substitutes
• Cell-based Matrices
• Bone Morphogenetic
• Demineralized Bone Matrix
• Synthetic Graft Extender
• Soft-Tissue Attachments
• Biological Mesh/Patch
• Synthetic Mesh/Patch
• Hemostatic Agents
• Thrombin-based Hemostatic Agents
• Oxidized Regenerated Cellulose-Based Hemostatic Agents
• Combined Hemostatic Agents
• Adhesions Barriers
• Synthetic Adhesion Barriers
• Natural Adhesion Barriers
• Surgical Sealants & Adhesives
• Staple Line Reinforcement Agents

End-use Outlook (Revenue, USD Billion; 2018-2028)

• Hospitals
• Clinics
• Ambulatory Surgical Centers
• Others

Inquiry Before Buying Research Report - https://www.reportsanddata.com/inquiry-before-buying/4612

Application Outlook (Revenue, USD Billion; 2018-2028)

• Orthopedic Surgery
• General Surgery
• Neurological Surgery
• Cardiovascular Surgery
• Gynecological Surgery
• Reconstructive Surgery
• Others

Regional Outlook (Revenue, USD Billion; 2018-2028)

• North America
• U.S.
• Canada
• Mexico
• Europe
• Germany
• U.K.
• France
• Italy
• Spain
• Sweden
• BENELUX
• Rest of Europe
• Asia Pacific
• China
• India
• Japan
• South Korea
• Rest of APAC
• Latin America
• Brazil
• Rest of LATAM
• Middle East & Africa
• Saudi Arabia
• U.A.E.
• South Africa
• Israel
• Rest of MEA

Similar Research reports by Reports and Data of Biotechnology Industry:

Antibody-drug conjugates (ADCs) market size was significantly large in 2020, and is expected to continue to register a rapidly inclining revenue CAGR between 2021 and 2028. Key factors responsible for driving market revenue growth are various advantages of antibody-drug conjugates over conventional treatment options for cancer and increasing prevalence of cancer across the globe.

Acute Repetitive Seizures Market, By Product Type (USL-261, NRL-1, AZ-002, Diastat Rectal Gel, Others), By End-use (Healthcare & Pharmaceuticals, Biotechnology, and Others), and By Region Forecast to 2028

Brain Bionics Market By Type (Deep Brain Simulators, Spinal Cord Simulators, Vagus Nerves Simulators), By Application (Hospitals, Clinics, Others), and By Region Forecast To 2028

Snake Anti-Venom Market Size, Share And Industry Analysis By Product Type (Polyvalent, Monovalent, and Others), By Species (Snake and Others), By End-Use (Hospitals, Clinics and Ambulatory Hospitals), and By Region Forecast to 2028

Cell and Tissue Preservation Market By Type (Media, Equipment, Accessories, Alarms, Monitoring Systems, and Incubators); By Application (Therapeutics, Research & Development, Drug Discovery, Cell Therapy, Gene Therapy, and IVF Treatments); and By Region Forecast To 2028

Cell Signaling Market By Product Type (Endocrine Signaling, Paracrine Signaling, Autocrine Signaling, Juxtacrine Signaling, and Others), By Product (Consumables and Instruments), By Application (Research and Medical), By Pathway, By Technology and By Region Forecast to 2028

About Reports and Data

RND is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

Contact Us:

John W
Head of Business Development
Reports And Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
LinkedIn | Twitter | Blogs

Read Latest Press Release @ https://www.reportsanddata.com/press-release/global-biosurgery-market

Logo: https://mma.prnewswire.com/media/1579615/Reports_and_Data_Logo.jpg